| angiogenesis |
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| cellular response to interleukin-1 |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. |
| cellular response to lipopolysaccharide |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. |
| cellular response to transforming growth factor beta stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus. |
| cellular response to xenobiotic stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organism exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
| defense response to Gram-negative bacterium |
Reactions triggered in response to the presence of a Gram-negative bacterium that act to protect the cell or organism. |
| dentinogenesis |
The process whose specific outcome is the formation of dentin, the mineralized tissue that constitutes the major bulk of teeth. Dentin may be one of three types: primary dentin, secondary dentin, and tertiary dentin. |
| female gonad development |
The process whose specific outcome is the progression of the female gonad over time, from its formation to the mature structure. |
| negative regulation of cell adhesion mediated by integrin |
Any process that stops, prevents, or reduces the frequency, rate, or extent of cell adhesion mediated by integrin. |
| negative regulation of cell migration |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell migration. |
| negative regulation of endopeptidase activity |
Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
| negative regulation of endothelial cell apoptotic process |
Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process. |
| negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. |
| negative regulation of fibrinolysis |
Any process that stops, prevents, or reduces the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots. |
| negative regulation of gene expression |
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| negative regulation of plasminogen activation |
Any process that decreases the rate, frequency or extent of plasminogen activation. Plasminogen activation is the process in which plasminogen is processed to plasmin. |
| negative regulation of smooth muscle cell migration |
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell migration. |
| negative regulation of smooth muscle cell-matrix adhesion |
Any process that stops, prevents, or reduces the frequency, rate or extent of smooth muscle cell-matrix adhesion. |
| negative regulation of vascular wound healing |
Any process that decreases the rate, frequency, or extent of blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature. |
| placenta development |
The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin. |
| positive regulation of angiogenesis |
Any process that activates or increases angiogenesis. |
| positive regulation of blood coagulation |
Any process that activates or increases the frequency, rate or extent of blood coagulation. |
| positive regulation of calcium ion import |
Any process that increases the rate, frequency, or extent of the directed movement of calcium ions into a cell or organelle. |
| positive regulation of coagulation |
Any process that activates or increases the frequency, rate or extent of coagulation. |
| positive regulation of collagen biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. |
| positive regulation of epithelium regeneration |
Any process that activates or increases the frequency, rate or extent of epithelium regeneration. |
| positive regulation of fibroblast proliferation |
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| positive regulation of inflammatory response |
Any process that activates or increases the frequency, rate or extent of the inflammatory response. |
| positive regulation of interleukin-8 production |
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
| positive regulation of keratinocyte migration |
Any process that activates or increases the frequency, rate or extent of keratinocyte migration. |
| positive regulation of leukotriene production involved in inflammatory response |
Any process that increases the rate, frequency or extent of the synthesis or release of any leukotriene following a stimulus as part of an inflammatory response. |
| positive regulation of monocyte chemotaxis |
Any process that increases the frequency, rate, or extent of monocyte chemotaxis. |
| positive regulation of odontoblast differentiation |
Any process that activates or increases the frequency, rate or extent of odontoblast differentiation. |
| positive regulation of receptor-mediated endocytosis |
Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport. |
| regulation of angiogenesis |
Any process that modulates the frequency, rate or extent of angiogenesis. |
| regulation of cell population proliferation |
Any process that modulates the frequency, rate or extent of cell proliferation. |
| regulation of signaling receptor activity |
Any process that modulates the frequency, rate or extent of a signaling receptor activity. Receptor activity is when a molecule combines with an extracellular or intracellular messenger to initiate a change in cell activity. |
| replicative senescence |
A cell aging process associated with the dismantling of a cell as a response to telomere shortening and/or cellular aging. |
